These findings corroborate our observations of the correlation between the activation of HGF/MET and Wnt/β-catenin signaling pathways in human CRPC samples and implicate a regulatory mechanism for co-activation of these pathways in promoting tumor progression and CRPC development. The gene discussed is HGF; the disease is neoplasm.